Oracle (NYSE:ORCL) PT Raised to $200.00 at Guggenheim

Oracle (NYSE:ORCLGet Free Report) had its price target upped by stock analysts at Guggenheim from $185.00 to $200.00 in a research note issued on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the enterprise software provider’s stock. Guggenheim’s target price would suggest a potential upside of 23.43% from the stock’s previous close.

A number of other brokerages have also recently issued reports on ORCL. Piper Sandler lifted their price target on shares of Oracle from $150.00 to $175.00 and gave the company an “overweight” rating in a research report on Tuesday, September 10th. BMO Capital Markets lifted their target price on shares of Oracle from $160.00 to $173.00 and gave the company a “market perform” rating in a report on Tuesday, September 10th. UBS Group upped their price target on Oracle from $160.00 to $175.00 and gave the stock a “buy” rating in a research note on Tuesday, September 10th. Deutsche Bank Aktiengesellschaft lifted their price objective on Oracle from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Monday, June 17th. Finally, Stifel Nicolaus increased their target price on Oracle from $135.00 to $155.00 and gave the stock a “hold” rating in a research note on Tuesday, September 10th. Eleven equities research analysts have rated the stock with a hold rating and eighteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $161.13.

Read Our Latest Analysis on Oracle

Oracle Stock Performance

Oracle stock opened at $162.03 on Friday. Oracle has a fifty-two week low of $99.26 and a fifty-two week high of $173.93. The stock’s 50 day simple moving average is $139.85 and its two-hundred day simple moving average is $130.03. The company has a debt-to-equity ratio of 6.68, a quick ratio of 0.72 and a current ratio of 0.72. The stock has a market cap of $446.53 billion, a price-to-earnings ratio of 43.67, a PEG ratio of 2.89 and a beta of 1.01.

Oracle (NYSE:ORCLGet Free Report) last released its quarterly earnings results on Monday, September 9th. The enterprise software provider reported $1.39 earnings per share for the quarter, beating the consensus estimate of $1.33 by $0.06. The company had revenue of $13.31 billion for the quarter, compared to analyst estimates of $13.23 billion. Oracle had a return on equity of 171.38% and a net margin of 20.40%. The firm’s revenue was up 6.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.95 earnings per share. As a group, analysts expect that Oracle will post 5.03 earnings per share for the current fiscal year.

Insider Transactions at Oracle

In related news, insider Edward Screven sold 235,918 shares of the firm’s stock in a transaction on Thursday, June 20th. The stock was sold at an average price of $144.30, for a total value of $34,042,967.40. Following the transaction, the insider now directly owns 2,626,764 shares of the company’s stock, valued at approximately $379,042,045.20. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Oracle news, Director Leon E. Panetta sold 15,000 shares of the company’s stock in a transaction that occurred on Thursday, July 18th. The shares were sold at an average price of $137.89, for a total value of $2,068,350.00. Following the completion of the transaction, the director now directly owns 58,090 shares in the company, valued at $8,010,030.10. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Edward Screven sold 235,918 shares of the stock in a transaction on Thursday, June 20th. The stock was sold at an average price of $144.30, for a total transaction of $34,042,967.40. Following the completion of the sale, the insider now directly owns 2,626,764 shares of the company’s stock, valued at $379,042,045.20. The disclosure for this sale can be found here. Insiders have sold 1,862,500 shares of company stock worth $266,776,624 in the last 90 days. 42.80% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Westend Capital Management LLC purchased a new position in shares of Oracle in the first quarter valued at about $25,000. Fairway Wealth LLC bought a new stake in Oracle during the 2nd quarter valued at approximately $27,000. Tidemark LLC purchased a new position in Oracle in the 4th quarter worth approximately $29,000. Frank Rimerman Advisors LLC bought a new position in Oracle in the 4th quarter worth approximately $30,000. Finally, POM Investment Strategies LLC purchased a new stake in Oracle during the 2nd quarter valued at approximately $30,000. Institutional investors own 42.44% of the company’s stock.

About Oracle

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Recommended Stories

Analyst Recommendations for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.